Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health

[In The News]

NEW YORK, March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced agreement...

View the full article